Skip to main content Skip to footer
American Family Children's Hospital
Keith C. Meyer, MD close
Keith C. Meyer, MD

New Patients

Need help selecting a primary care doctor? Contact the Welcome Center for personal assistance.

For Referring Physicians

How to refer a patient

Keith C. Meyer, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Meyer is part of the UW Health Performing Arts Medicine program. He is dedicated to the care of performing artists in a timely and customized manner.


Pulmonary and Critical Care Medicine

Advanced Lung Disease




Chronic Obstructive Pulmonary Disease

Cystic Fibrosis

Deep Vein Thrombosis

Hypersensitivity Pneumonitis

Idiopathic Pulmonary Fibrosis

Immunodeficiency Disorders

Interstitial Lung Disease

Lung Transplant

Malignant and benign pleural disease

Medical Management of Lung Transplant Patients

Pediatric Allergy, Asthma and Immunology

Performing Arts Medicine

Pulmonary Function Test

Pulmonary Infections

Pulmonary Stress Test

Pulmonary Vascular Disease



Vascular Surgery


University Hospital
(608) 263-7203 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Internal Medicine
Pulmonary Disease
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI

Languages Spoken

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Kojima T Laverriere EK Owen EB Harwayne-Gidansky I Shenoi AN Napolitano N Rehder KJ Adu-Darko MA Nett ST Spear D Meyer K Giuliano JS Jr Tarquinio KM Sanders RC Jr Lee JH Simon DW Vanderford PA Lee AY Brown CA 3rd Skippen PW Breuer RK Toedt-Pingel I Parsons SJ Gradidge EA Glater LB Culver K Li S Polikoff LA Howell JD Nuthall G Bysani GK Graciano AL Emeriaud G Saito O Orioles A Walson K Jung P Al-Subu AM Ikeyama T Shetty R Yoder KM Nadkarni VM Nishisaki A National Emergency Airway Registry for Children (NEAR4KIDS) Collaborators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI). Clinical Impact of External Laryngeal Manipulation During Laryngoscopy on Tracheal Intubation Success in Critically Ill Children. Pediatr Crit Care Med . 2018 Feb;19(2):106-114
[PubMed ID: 29140970]
Haynes LD Julliard W Mezrich J Leverson G Meyer KC Burlingham WJ Specific Donor HLA-DR Types Correlate with Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction. Transplantation . 2018 Jan 23;
[PubMed ID: 29360666]
Newton CA Batra K Torrealba J Meyer K Raghu G Garcia CK Pleuroparenchymal fibroelastosis associated with telomerase reverse transcriptase mutations. Eur Respir J . 2017 May;49(5)
[PubMed ID: 28495683]
Meyer KC Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med . 2017 May;11(5):343-359
[PubMed ID: 28345383]
Meyer KC Pulmonary fibrosis, part II: state-of-the-art patient management. Expert Rev Respir Med . 2017 May;11(5):361-376
[PubMed ID: 28345369]
Meyer KC Decker CA Role of pirfenidone in the management of pulmonary fibrosis. Ther Clin Risk Manag . 2017;13:427-437
[PubMed ID: 28435277]
Meyer KC Great expectations for simtuzumab in IPF fall short. Lancet Respir Med . 2017 Jan;5(1):2-3
[PubMed ID: 27939077]
Newton CA Batra K Torrealba J Kozlitina J Glazer CS Aravena C Meyer K Raghu G Collard HR Garcia CK Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J . 2016 Dec;48(6):1710-1720
[PubMed ID: 27540018]
Lushaj E Julliard W Akhter S Leverson G Maloney J Cornwell RD Meyer KC DeOliveira N Timing and Frequency of Unplanned Readmissions After Lung Transplantation Impact Long-Term Survival. Ann Thorac Surg . 2016 Aug;102(2):378-84
[PubMed ID: 27154148]
Meyer KC Multidisciplinary discussions and interstitial lung disease diagnosis: how useful is a meeting of the minds? Lancet Respir Med . 2016 Jul;4(7):529-31
[PubMed ID: 27180020]
Meyer KC Diagnosis and management of bronchiolitis obliterans syndrome following lung or hematopoietic cell transplantation. Expert Rev Respir Med . 2016 Jun;10(6):599-602
[PubMed ID: 26950825]
Julliard WA Meyer KC De Oliveira NC Osaki S Cornwell RC Sonetti DA Maloney JD The presence or severity of pulmonary hypertension does not affect outcomes for single-lung transplantation. Thorax . 2016 May;71(5):478-80
[PubMed ID: 26621135]
Meyer KC Gastroesophageal reflux and lung disease. Expert Rev Respir Med . 2015 Aug;9(4):383-5
[PubMed ID: 26104973]
Meyer KC Danoff SK Lancaster LH Nathan SD Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions. Chest . 2015 Jul;148(1):242-252
[PubMed ID: 26149553]
Rosenbaum JN Butt YM Johnson KA Meyer K Batra K Kanne JP Torrealba JR Pleuroparenchymal fibroelastosis: a pattern of chronic lung injury. Hum Pathol . 2015 Jan;46(1):137-46
[PubMed ID: 25454481]
Meyer KC Raghu G Verleden GM Corris PA Aurora P Wilson KC Brozek J Glanville AR ISHLT/ATS/ERS BOS Task Force Committee. ISHLT/ATS/ERS BOS Task Force Committee. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J . 2014 Dec;44(6):1479-503
[PubMed ID: 25359357]
Schmidt A Belaaouaj A Bissinger R Koller G Malleret L D'Orazio C Facchinelli M Schulte-Hubbert B Molinaro A Holst O Hammermann J Schniederjans M Meyer KC Damkiaer S Piacentini G Assael B Bruce K Häußler S LiPuma JJ Seelig J Worlitzsch D Döring G Neutrophil elastase-mediated increase in airway temperature during inflammation. J Cyst Fibros . 2014 Dec;13(6):623-31
[PubMed ID: 24713593]
Nathan SD Meyer KC IPF clinical trial design and endpoints. Curr Opin Pulm Med . 2014 Sep;20(5):463-71
[PubMed ID: 25022315]
Meyer KC Immunosuppressive agents and interstitial lung disease: what are the risks? Expert Rev Respir Med . 2014 Jun;8(3):263-6
[PubMed ID: 24649876]
Meyer KC The clinical utility of bronchoalveolar lavage in interstitial lung disease - is it really useful? Expert Rev Respir Med . 2014 Apr;8(2):133-5
[PubMed ID: 24450398]